JosephDavidMeserveMD

PubMed

• Development of an MRI-Based Prediction Model for Anti-TNF Treatment Failure in Perianal Crohn's Disease: A Multicenter Study.
  McCurdy, J., Munir, J., Parlow, S., Reid, J., Yanofsky, R., Alenezi, T., Meserve, J., Becker, B., Lahijanian, Z., Eddin, A., Mallick, R., Ramsay, T., Rosenfeld, G., Be...> ;Clinical Gastroenterology and Hepatology. 2023 Dec 18
• 2 citations
  Temporary Faecal Diversion for Refractory Perianal and/or Distal Colonic Crohn's Disease in the Biologic Era: An Updated Systematic Review with Meta-analysis.
  Michael Jew, Joseph Meserve, Samuel Eisenstein, Vipul Jairath, Jeffrey McCurdy, Siddharth Singh> ;Journal of Crohn's & Colitis. 2024 Mar 1
• Editorial: risk of pneumonia in IBD-reading between the lines!
  Joseph Meserve, Siddharth Singh> ;Alimentary Pharmacology & Therapeutics. 2021 Dec 1
• 14 citations
  Effectiveness of Re-induction and/or Dose Escalation of Ustekinumab in Crohn's Disease: A Systematic Review and Meta-analysis.
  Joseph Meserve, Christopher Ma, Parambir S. Dulai, Vipul Jairath, Siddharth Singh> ;Clinical Gastroenterology and Hepatology. 2021 Oct 7
• 15 citations
  Paternal Exposure to Immunosuppressive and/or Biologic Agents and Birth Outcomes in Patients With Immune-Mediated Inflammatory Diseases.
  Joseph Meserve, Jiyu Luo, Wenhong Zhu, Nina Veeravalli, Gretchen Bandoli, Christina D. Chambers, Abha G. Singh, Brigid S. Boland, William J. Sandborn, Uma Mahadevan, S...> ;Gastroenterology. 2021 Jul 1
• Correction to: Understanding Determinants of Patient Preferences Between Stool Tests and Colonoscopy for the Assessment of Disease Activity in Inflammatory Bowel Disease.
  Maria Barsky, Joseph Meserve, Helen Le, Angelina Collins, Siddharth Singh, Brigid Boland, William J Sandborn, Parambir S Dulai> ;Digestive Diseases and Sciences. 2021 Sep 1
• 4 citations
  Pathologist, Meet Picasso! Virtual Chromoendoscopy for Detecting Histologic Remission in Ulcerative Colitis.
  Joseph Meserve, Siddharth Singh> ;Gastroenterology. 2021 Jan 25
• 43 citations
  Systematic review with meta‐analysis: safety and tolerability of immune checkpoint inhibitors in patients with pre‐existing inflammatory bowel diseases
  Joseph Meserve, Antonio Facciorusso, Ariela K. Holmer, Vito Annese, William J. Sandborn, Siddharth Singh> ;Alimentary Pharmacology & Therapeutics. 2021 Feb 1
• 25 citations
  Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis.
  Dana J. Lukin, David Faleck, Ronghui Xu, Yiran Zhang, A Weiss, Satimai Aniwan, Siri Kadire, Gloria Tran, Mahmoud A. Rahal, Adam Winters, Shreya Chablaney, Jenna L. Kol...> ;Clinical Gastroenterology and Hepatology. 2020 Oct 8
• 5 citations
  Understanding Determinants of Patient Preferences Between Stool Tests and Colonoscopy for the Assessment of Disease Activity in Inflammatory Bowel Disease.
  Maria Barsky, Joseph Meserve, Helen Le, Angelina Collins, Siddharth Singh, Brigid Boland, William J Sandborn, Parambir S Dulai> ;Digestive Diseases and Sciences. 2021 Aug 1
• 11 citations
  Predicting Response to Vedolizumab in Inflammatory Bowel Disease.
  Joseph Meserve, Parambir S. Dulai> ;Frontiers in Medicine. 2020 Apr 2
• 36 citations
  Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis.
  Parambir S. Dulai, Siddharth Singh, Niels Vande Casteele, Joseph Meserve, Adam Winters, Shreya Chablaney, Satimai Aniwan, Preeti Shashi, Gursimran Kochhar, A Weiss, Je...> ;Clinical Gastroenterology and Hepatology. 2020 Feb 13
• 37 citations
  Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn's Disease But Not Ulcerative Colitis
  David Faleck, Adam Winters, Shreya Chablaney, Preeti Shashi, Joseph Meserve, A Weiss, Satimai Aniwan, Jenna L. Koliani-Pace, Gursimran Kochhar, Brigid S. Boland, Siddh...> ;Clinical Gastroenterology and Hepatology. 2019 Nov 1
• 8 citations
  Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes
  Jenna L. Koliani-Pace, Siddharth Singh, Michelle Luo, Robert Hirten, Satimai Aniwan, Gursimran Kochhar, Shannon Chang, Dana J. Lukin, Youran Gao, Matthew Bohm, Arun Sw...> ;Inflammatory Bowel Diseases. 2019 Oct 18
• 3 citations
  In the absence of head-to-head trials, what do real world studies tell us about the comparative effectiveness of biologics in Crohn's disease.
  Joseph Meserve, Maria Barsky, Parambir S. Dulai> ;Best Practice & Research. Clinical Gastroenterology. 2019 Feb 1
• 48 citations
  Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease.
  Eugenia Shmidt, Gursimran Kochhar, Justin Hartke, Prianka Chilukuri, Joseph Meserve, Khadija Chaudrey, Jenna L. Koliani-Pace, Robert Hirten, David Faleck, Morris Baroc...> ;Inflammatory Bowel Diseases. 2018 Oct 12
• 52 citations
  Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases.
  Joseph Meserve, Satimai Aniwan, Jenna L. Koliani-Pace, Preeti Shashi, A Weiss, David Faleck, Adam Winters, Shreva Chablaney, Gursimran Kochhar, Brigid S. Boland, Siddh...> ;Clinical Gastroenterology and Hepatology. 2019 Jul 1
• 79 citations
  Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn’s Disease
  Parambir S. Dulai, Brigid S. Boland, Siddharth Singh, Khadija Chaudrey, Jenna L. Koliani-Pace, Gursimran Kochhar, Malav P. Parikh, Eugenia Shmidt, Justin Hartke, Prian...> ;Gastroenterology. 2018 Sep 1
• Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.
  Narula, N.,Peerani, F.,Meserve, J.,Kochhar, G.,Chaudrey, K.,Hartke, J.,Chilukuri, P.,Koliani-Pace, J.,Winters, A.,Katta, L.,Shmidt, E.,Hirten, R.,Faleck, D.,Parikh, M....> ;Am. J. Gastroenterol.. 2018 Jun 28
• 3 citations
  Correction to: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium (The American Journal of Gastroenterology, (2018), 113, 9, (1345-1354...
  Neeraj Narula, Farhad Peerani, Joseph Meserve, Gursimran Kochhar, Khadija Chaudrey, Justin Hartke, Prianka Chilukuri, Jenna L. Koliani-Pace, Adam Winters, Leah Katta, ...> ;The American Journal of Gastroenterology. 2018 Jan 1
• 11 citations
  Disseminated Herpes Simplex Virus with Fulminant Hepatitis.
  Bassam H. Rimawi, Joseph Meserve, Ramzy H. Rimawi, Zaw Min, John W. Gnann> ;Case Reports in Hepatology. 2015 Jul 28
• Join now to see all

Journal Articles

• Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium  
  Leah Katta, Robert Hirten, Shannon Chang, Dana Lukin, Edward V Loftus, David Faleck, Arun Swaminath, William J Sandborn, Sashidhar Varma Sagi, Sunanda Kane, Prianka Ch..., Nature
• Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium  
  Gursimran Kochhar, Justin Hartke, Sashidhar Varma Sagi, Edward V Loftus, Joseph Meserve, Robert Hirten, David Faleck, Shannon Chang, Dana Lukin, Farhad Peerani, Leah K..., Nature